STOCK TITAN

Femasys (NASDAQ: FEMY) director Joshua Silverman files neutral Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Femasys Inc director reports no new trades. This Form 4 filing lists Joshua Silverman as a director of Femasys Inc but shows no reported transactions in company securities. The transaction summary indicates zero buys, sells, exercises, gifts, or other dispositions, reflecting neutral net trading activity for this period.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Silverman Joshua

(Last)(First)(Middle)
C/O FEMASYS INC
3950 JOHNS CREEK COURT, SUITE 100

(Street)
SUWANEE GEORGIA 30024

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Effective March 17, 2026, the Reporting Person resigned from his role as a director of the Issuer. As a result, the Reporting Person is no longer subject to Section 16 in connection with his transactions in the equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5.
/s/ Joshua N. Silverman, President and CEO03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What does Joshua Silverman’s Form 4 for FEMASYS INC (FEMY) show?

The Form 4 shows no reported transactions by director Joshua Silverman in FEMASYS INC securities. All transaction counts, including buys, sells, and option exercises, are zero, indicating neutral net trading activity for this reporting period.

Were any FEMASYS INC (FEMY) shares bought or sold in this Form 4?

No. The Form 4 transaction summary reports zero buy and zero sell transactions, with netBuySellShares shown as 0 and netBuySellDirection labeled “neutral,” meaning no share purchases or sales were disclosed for this period.

Does this FEMASYS INC (FEMY) Form 4 include any option exercises?

No. The derivative-related fields show exerciseCount and exerciseShares at 0, and derivativeTransactionCount is also 0. This indicates there were no option or other derivative exercises reported in this Form 4 filing.

Are there any gifts or tax-withholding transactions in FEMY’s Form 4?

No. The transactionSummary lists giftCount and giftShares as 0 and taxWithholdingCount and taxWithholdingShares as 0. This means there were no reported gifts or tax-withholding share dispositions during the covered period.

What is the overall trading direction in this FEMASYS INC Form 4?

The overall direction is neutral. The transactionSummary shows netBuySellShares of 0 and netBuySellDirection labeled “neutral,” reflecting that no buying, selling, or other share-changing transactions were reported in this filing.
FEMASYS INC

NASDAQ:FEMY

View FEMY Stock Overview

FEMY Rankings

FEMY Latest News

FEMY Latest SEC Filings

FEMY Stock Data

33.17M
54.54M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE